cartouche ECN WORKSHOP
-

Abstracts

Oral communications

1

2021 - Oral communication

OA-Genetics and EUROGOUT-Inflammation

Does excess weight affect gout risk differently among genetically predisposed individuals? Sex-specific prospective cohort findings over >26 years

Chio Yokose (1,2); Natalie Mccormick (1,2,3); Na Lu, (3,4); Amit D. Joshi, Mbbs (5); Hyon K. Choi (1,2,3,4)

3

2021 - Oral communication

Therapeutics-Miscellaneous

Effect of leflunomide on pegloticase response rate in patients with uncontrolled gout

Karim Richard Masri (1), Kevin Winterling (1), Brian Lamoreaux (2)

5

2021 - Oral communication

OA-Genetics and EUROGOUT-Inflammation

Translating the multi-trait regulatory landscape at SLC2A9

Megan Leask, James Boocock, Hyon Choi, Tayaza Fadason, Justin O’Sullivan, Lisa Stamp, Nicola Dalbeth, Julia Horsfield, Tony R Merriman

6

2021 - Oral communication

Medication taking behavior of allopurinol treatment among patients with gout: a retrospective cohort study in the clinical practice research datalink (CPRD)

Scheepers L.E.J.M. (1), Burden A. M. (2), Spaetgens B. (1, 2) , Arts I.C.W. (3), de Vries F. (2), A. Boonen A. (1)

7

2021 - Oral communication

Therapeutics-Miscellaneous

Microglia control small vessel calcification via TREM2

Yvette Zarb (1) , Sina Nassiri (2), Sebastian Guido Utz (3), Johanna Schaffenrath (1), Mauro Delorenzi (2), Marco Colonna (4), Melanie Greter (3), Annika Keller(1)

8

2021 - Oral communication

Failure to reach serum urate target is associated with elevated mortality in gout

F. Pérez-Ruiz (1), P. Richette (2), A. G. Stack (3), R. Karra Gurunath (4), M. J. García De Yebenes (5), L. Carmona (5)

9

2021 - Oral communication

Therapeutics-Miscellaneous

Effect of metformin on clinical gout outcomes in gout patients with diabetes mellitus

F. Veenstra (1), Lm. Verhoef (1), M. Opdam (1), Aa. Den Broeder (1,3), W. Kwok (2), I. Meek (3, Fhj. Van Den Hoogen (1,3), M. Flendrie (1), N. Van Herwaarden (1,3)

10

2021 - Oral communication

OA-Genetics and EUROGOUT-Inflammation

Recent findings in clinico-genetics analyses for clinically-defined gout

Hirotaka Matsuo (1), Masahiro Nakatochi (2), Akiyoshi Nakayama (1), Yusuke Kawamura (1), Yu Toyoda (1), Seiko Shimizu (1), Tappei Takada (3), Kimiyoshi Ichida (4), Nariyoshi Shinomiya (1), Yukinori Okada (5)

11

2021 - Oral communication

Therapeutics-Miscellaneous

Outcomes of care among patients with gout in europe: a cross-sectional survey

Ritch Te Kampe (1,2), Tim L. Jansen (2), Caroline Van Durme (1), Matthijs Janssen (2), Gudula Petersen (3), Annelies Boonen (1)

12

2021 - Oral communication

OA-Genetics and EUROGOUT-Inflammation

CD11B deficiency promotes inflammasome activation in macrophages and aggravates MSU-induced joint inflammation in mice

Driss Ehirchiou, Ilaria Bernabei, Veronique Chobaz, Sonia Nasi, Mariela Castelblanco , Alexander So , Hans Acha-Orbea, Thomas Hugle, Li Zhang, Nathalie Busso

13

2021 - Oral communication

Mechanisms of Calcification

The gasotransmitter hydrogen sulfide (H2S) is protective against calcific tendinopathy (CT)

Bernabei I. (1), Kronenberg D. (2), Stange R. (2), Bertrand J. (3), Hügle T (1), So A. (1, Busso N. (1), Nasi S. (1)

14

2021 - Oral communication

Mechanisms-Epidemiology

The inflammatory role of the silent urate crystal deposition in intercritical gout

Cesar Diaz-Torne (1), Maria A. Ortiz (2), Sicylle Jeria-Navarro (1), Andrea Garcia-Guillem (1), Lluis Sanz (1), Susana Hernandez (1), Silvia Vidal (2)

15

2021 - Oral communication

Mechanisms-Epidemiology

Is repeat serum urate testing superior to a single test to predict incident gout over time?

Sarah Stewart, Amanda Phipps-Green, Greg D. Gamble, Lisa K. Stamp, William J. Taylor, Tuhina Neogi, Tony R. Merriman, Nicola Dalbeth

17

2021 - Oral communication

Mechanisms of Calcification

Active screening for gout identifies a larger cardiovascular population at high mortality risk.

Silvia Ruiz-Simón, Medical Student; Irene Calabuig, Md; Miguel Gómez-Garberí, Md; Mariano Andrés, Md, Phd.

18

2021 - Oral communication

Therapeutics-Miscellaneous

A precise identification of crystal deposits in the kidney tissue

Frochot V, Jouanneau C, Letavernier E, Haymann JPh, Bazin D, Daudon M.

Posters